• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

drug rep

  1. prescription data & kickbacks at Insys

    I'm a writer working on a story for publication re: the impact of IQVIA (and similar) data on healthcare. Did INSYS use prescription data to allocate kickbacks based on prescription volume of certain docs? You can reach me at: medwriter963@gmail.com. Thank you.
  2. PDRP violations

    I am a medical writer looking for someone willing to go on the record regarding violations of PDRP (physician data restriction program) by drug manufacturers. That is, I'm interested knowing about prescription info of PDRP doctors being made available to drug reps. I look forward to hearing...
  3. Diary of a Drug Rep

    Many older reps from Cafepharma may remember a very famous viral email parody called “Diary of a Drug Rep”. It came out in the early 2000’s before social media was in full blast. It spread like wildfire mostly through the reps themselves. A link to a poster made from it is here. I was the...